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Background: Kleefstra syndrome is characterized by intellectual disability, muscular hypotonia in childhood and
typical facial features. It results from either a microdeletion of or a deleterious sequence variant in the gene
euchromatic histone-lysine N-methyltransferase 1 (EHMT1) on chromosome 9q34.
Results: We report on a 3-year-old girl with characteristic symptoms of Kleefstra syndrome. Array comparative
genomic hybridization analysis revealed a 145 kilobases duplication spanning exons 2 to 10 of EHMT1. Sequence
analysis characterized it as an intragenic tandem duplication leading to a frame shift with a premature stop codon
in EHMT1.
Conclusions: This is the first description of an intragenic duplication of EHMT1 resulting in Kleefstra syndrome.
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Kleefstra syndrome (KS; OMIM #610253) is a clinically
well described genetic disorder characterized by the phe-
notypical core features of psychomotoric retardation/
intellectual disability (ID), muscular hypotonia and char-
acteristic facial dysmorphisms. The underlying cause of
KS is - in approximately 75% - a microdeletion in the
chromosomal region 9q34 leading to either a partial or an
entire EHMT1 loss [1-4]. The other causes of KS are het-
erozygous intragenic loss-of-function mutations in the
EHMT1 gene (~25%; OMIM *607001) [1-4]. There seems
to be no clear genotype-phenotype correlation regarding
patients with microdeletions in 9q34 and intragenic muta-
tions in EHMT1 [3,4]. Duplications of the entire or partial
EHMT1 gene have been reported [5,6] but none of these
duplications was strictly intragenic and none of them led
to a KS phenotype.
EHMT1 encodes for a methyltransferase specific for
lysine-9 of histone H3 and is a component of the tran-
scription factor E2F6, which can repress gene trans-
cription [7]. E2F6-methylation by EHMT1 is probably* Correspondence: eva.schwaibold@med.uni-goettingen.de
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remodeling [7].
Here, we describe for the first time a patient with the
typical symptoms of KS carrying a 145 kilobases (kb) in-
tragenic duplication in the EHMT1 gene. The submicro-
scopic duplication in EHMT1 was detected by array
comparative genomic hybridization (aCGH). Transcript
analysis revealed a tandem duplication leading to a
frame shift and a premature stop codon, suggesting hap-
loinsufficiency as the underlying cause of KS [1,3,8].
Case presentation
Case report
The patient is the third child of healthy non-consanguinous
parents. She has two healthy older brothers. Her mother
had an intellectually disabled half-brother. Her father’s pa-
ternal uncle died directly after birth for unknown reasons.
Prenatal ultrasound demonstrated a fetal constitutional
growth delay, a polyhydramnion and a single umbilical ar-
tery. The girl was born spontaneously at 39 weeks gesta-
tion. Her birth length, her birth weight and her head
circumference were between the 3rd and the 10th centile.
Apgar scores were 9/9/9.
Developmental delay was first noted at 3 months of age.
The girl showed marked muscular hypotonia. At 2 yearsntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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Schwaibold et al. Molecular Cytogenetics 2014, 7:74 Page 2 of 5
http://www.molecularcytogenetics.org/content/7/1/74of age she could sit without support but was still not able
to crawl or walk at the age of 3 years.
She tended to be very quiet and did not react to
sounds. A hearing test was anamnestically normal. The
girl began to vocalize and starts teeth grinding when she
was one year old but she could not speak at the age of
3 years.
She displayed autistic features with stereotypic move-
ments and the vocalization of clicking voices with her
tongue. At 3 years of age she attended a special nursery.
Cranial MRIs at the age of 2 and 3 years, respectively,
revealed unspecific bilateral T2-hyperintense white mat-
ter changes in the occipital region. An electroencephalo-
gram at the age of 3 years was normal.
Echocardiography demonstrated a haemodynamically
irrelevant patent foramen ovale and a mild peripheral
pulmonary stenosis. Myocardial function was normal.
At 2 11/12 years of age the patient displayed the follow-
ing facial features (Figure 1a-b): square, brachycephalic
face with a prominent forehead and frontal bossing, slight
midface hypoplasia, hypertelorism with mildly downslant-
ing palpebral fissures, synophris, small nose with ante-
verted nostrils and deep-set nasal root, mild prognathism,
deep-set posterior rotated ears, full cheeks and prominent
philtrum. The girl held her mouth mostly opened with a
cupid bowed upper lip, full lower lip and a slightly pro-
truding tongue. An ophthalmologic examination con-
firmed an intermittent exotrophy. The patient’s soles
of the feet were deeply creased in their frontal part
(Figure 1c). Her back was hairy (Figure 1d).
Results
Array CGH analysis in our patient revealed a subter-
minal duplication on chromosome 9q34.4. The size was
approximately 145 kb, spanning positions 140.535.164
to 140.657.526 (arr 9q34.3(140,527,261x2,140,535,164-
140,657,526x3,140,672,499x2); GRCh37/hg19; ISCN 2013;
Figure 2a). The duplication was verified by qPCR (data
not shown). The parents’ array CGH analyses as well asFigure 1 Representative photographs of the patient at 2 11/12 years
prominent forehead, hypertelorism with mildly downslanting palpebral fiss
nostrils and deep-set nasal root, mild prognathism, deep-set posterior rotat
mouth with cupid bowed upper lip and full lower lip. (c) The frontal part ostandard karyotyping were normal (data not shown) con-
firming the de novo origin of the duplication.
The only gene in the duplicated region was EHMT1
(Figure 2a). According to the array CGH results the cen-
tromerically located breakpoint of the duplication was
within intron 1 of EHMT1, the terminally located break-
point was between intron 10 and exon 13 of EHMT1. As
microdeletions as well as sequence variants but not micro-
duplications of or within EHMT1 are known to cause KS
and our patient’s symptoms were typical for KS the pos-
sible pathogenic background was examined.
First, the terminal breakpoint of the duplication was
narrowed down to intron 10 of EHMT1 by qPCR using
exon-specific primers for the chromosomal region be-
tween positions 140.535.164 to 140.657.526. It was dem-
onstrated that the duplication spanned exon 2 to exon
10 of EHTM1 (data not shown). There were several pos-
sibilities regarding the localization and the orientation of
the duplication but one of the two RNA transcripts
shown in Figure 2b seemed most likely. Therefore, PCRs
with the patient’s cDNA and primer sequences specific
for the possible PCR products A (exon 10 adjacent to
exon 2 of the coding EHTM1 gene) and B (exon 2 adja-
cent to exon 11 of the coding EHTM1 gene), respect-
ively, were performed. Primers for the PCR product of
exon 10 adjacent to exon 11 and the PCR product span-
ning exons 2 to 10, respectively, were used as positive
controls for the primer function (data not shown). A
PCR product was only obtained for A (Figure 2c, first
lane) and for the positive controls (data not shown), not
for B (Figure 2c, second lane) and not with the DNA
sample of a control person (Figure 2c, third and fourth
lane). By obtaining this PCR product transcript degrad-
ation that would be suggestive for nonsense mediated
mRNA decay seemed to be rather unlikely. PCR product
A was directly sequenced and compared with the se-
quences of both, exon 2 and exon 10, in wildtype EHMT1
(ENST00000460843). The duplication within EHMT1 re-
sulted in a frameshift and a premature stop codon in theof age. (a-b) The main facial features of the girl were: brachycephaly,
ures, intermittent exotrophy, synophris, small nose with anteverted
ed ears, full cheeks and prominent philtrum. Note the mostly opened
f her plantar feet was deeply creased. (d) Her back was hairy.
Figure 2 Microduplication within EHMT1 gene results in KS. (a) aCGH identified a 145 kb duplication (greenish shaded; enlarged on the right
side of Figure 2a) within the EHMT1 gene (arrow) on chromosome 9q34.4. Log 2 ratio data for two dye-swap plots (patient/control) are presented
according to their positions in the human genome. The light blue shaded region with blue and red dots indicates the moving average. Chr.9:
chromosome 9. (b) Schematic overview of the two possible cDNA transcripts of EHMT1 gene in our patient that seemed most likely. Black: normal
EHMT1 gene transcript. Red: duplicated region of EHMT1 in our patient. ex: exon. A: indicates a possible PCR product (exon 10 of the duplicated
region adjacent to exon 2 of the normal EHMT1 transcript). B: indicates a possible PCR product (exon 2 of the duplicated region adjacent to exon
11 of normal coding EHTM1 transcript). (c) Agarose gel electrophoresis of possible PCR products A and B (see Figure 2b) in our patient (first and
second lane) and a control person (third and forth lane). A PCR product was only seen for A in our patient. It showed the expected size of
~190 bp of PCR product A according to the 1 kb Plus DNA Ladder (Invitrogen, Carlsbad, CA). (d) Sequence analysis of PCR product A (Figure 2c)
and comparison with the normal coding transcript of EHTM1 gene revealed a frameshift in the coding sequence leading to a premature stop
codon (green box) in EHMT1 in our patient. Exon 10 adjacent to exon 2 of the forward strand of EHMT1 coding sequence in our patient is shown.
Grey shaded boxes: localization of the constructed forward (fw) and reverse (rv) primers, respectively. Black: coding sequence of exon 10 of
EHMT1. Red: coding sequence of exon 2 of EHMT1.
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our patient (Figure 2d).Discussion
Array CGH revealed a 145 kb duplication within the
EHMT1 gene in our patient (Figure 2a). A detailed ana-
lysis of the duplicated region within EHMT1 in our pa-
tient by qPCR and cDNA analysis revealed a direct
tandem duplication of exons 2 to 10 of the EHMT1 gene
(Figure 2c).
Patients with duplications in the region of EHMT1
have been reported [5,6] but the duplications included
either the whole EHMT1 gene, additionally the adjacent
chromosomal region or one or multiple adjacent genes.
Only one patient with a EHMT1 duplication spanning
exons 1 to 16 is described in the literature [5]. This pa-
tient does not display a KS phenotype but autistic fea-
tures and behavioral problems [5]. The patient had a
tandem duplication with both copies of EHMT1 being
probably functional. Due to the duplication in our pa-
tient a premature stop codon in the additionally inserted
exon 2 is generated (Figure 2d). It is very likely that the
premature termination of the protein EHMT1 will impairor reduce its function although we could not directly
prove haploinsufficiency of EHMT1. In contrast, increased
dosage of EHMT1 - as in the other patient - might lead to
neurodevelopmental impairment [5].
A possible explanation for the location of the duplica-
tion in our patient could be the existence of repetitive
DNA elements in EHMT1 in the breakpoint region of
the duplication. Repetitive DNA elements in general -
and Alu elements in particular - are prone for non-allelic
homologues recombinations that can lead to disease caus-
ing chromosomal aberrations [9]. According to the
RepeatMasker Web Server [10] both, intron 1 and intron
10 of EHMT1 gene, contain high amounts of repetitive
DNA elements (intron 1: 58,13% total interspersed repeats
(TIRs); intron 10: 49,07% TIRs). The adjacent introns 2, 9
and 11, respectively, have lower amounts of repetitive ele-
ments. In intron 1 especially the amount of Alu elements
that belong to the short interspersed elements was higher
than in intron 2 (31,53% vs. 19.30%). The high rate of re-
petitive elements - especially Alu elements - in the break-
point regions of the duplication in our patient provides a
plausible explanation for the localization of the duplica-
tion. Likely, there will be further KS patients with de-
letions or duplications leading to haploinsufficiency of
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the affected introns reported here.
Our patient displayed the typical phenotype of KS
[1-4,11]; (Table 1). Only minor phenotypical differences
were observed, e.g. our patient had a very hairy back and
was almost underweight, both features not typically seen
in KS.
Conclusions
For the first time we could show that a duplication
within the EHMT1 gene leads to KS in a patient due toTable 1 Clinical findings of our patient compared with




patients with KS and
EHMT1 defect (%)
Psychomotoric retardation/ ID + 100%




















Thick/everted lower lip + 25%




Arched eyebrows - 30%
Pointed chin - 25%
Prominent forehead + n. r.
Neurologic defects:
Structural CNS anomalies - n. r.
Seizures - 25%
Renal anomalies - 15%
Sensorineural hearing loss - 15%
Deeply creased soles of the feet + n. r.
Hairy back + n. r.
+ denotes present, − denotes absent; n. r. = not reported; KS = Kleefstra
syndrome; ID = intellectual disability; Table modified from [11].the creation of a premature stop codon in EHMT1 that
will probably impair/reduce the protein function. The
gene EHMT1 seems to be dosage sensitive with a de-
crease of gene expression resulting in KS and an in-
crease of gene expression leading to a milder phenotype
with an impaired neurodevelopment. The phenotype dis-
played by our patient is very similar compared with the
previously reported KS patients and confirms the notion
that there is no strong genotype-phenotype correlation
in KS.
Methods
DNA and RNA preparation
Blood samples were collected from the patient and her
parents after obtaining the parents’ signed informed con-
sent. Total genomic DNA was prepared using standard
techniques. RNA isolation was performed from a blood
sample of our patient using the PAXgene™ Blood RNA
kit 50v2 (PreAnalytix, Qiagen, Venlo, The Netherlands)
according to the manufacturer’s instructions. cDNA
was obtained using the Superscript II Kit (Invitrogen,
Carlsbad, CA).
aCGH
Genome-wide copy number scans were performed with
the patient’s and her parents’ lymphocyte DNA using an
Agilent SurePrint G3 Human CGH Microarray Kit 4 ×
180 K and was read using an Agilent Microarray Scanner
G256BA and G5761A, respectively, along with Agilent
Feature Extraction Software V9.1 (Agilent Technologies,
Inc., Santa Clara, CA) according to the manufacturer’s in-
structions. The results were analyzed using Agilent Cyto-
genomics 2.0 and 2.5 software, respectively. Array CGH
data was confirmed by quantitative real time PCR (qPCR).
EHMT1 gene analysis
qPCR was used to narrow down the C-terminal break-
point in the EHMT1 gene by designing specific primers
for exon 6 to 17 of the EHMT1 gene (ENST00000460843).
PCRs were performed to amplify the possible transcripts
of the EHMT1 gene in our patient. The obtained PCR
products were directly sequenced on the ABI 3500xL
Genetic Analyzer (Applied Biosystems, Foster City, CA).
Their sequence was compared with the sequence of nor-
mal EHMT1 coding transcript (ENST00000460843). All
primer sequences and PCR conditions are available on
request.
Cytogenetic analysis
Metaphase chromosome spreads of blood samples of the
patient’s parents were prepared from phytohemagglu-
tinin (PHA)-stimulated peripheral blood cultures using
standard protocols. 10 and 11, respectively, GTG-banded
metaphases were analyzed.
Schwaibold et al. Molecular Cytogenetics 2014, 7:74 Page 5 of 5
http://www.molecularcytogenetics.org/content/7/1/74Consent
Written informed consent was obtained from the par-
ents of the patient for publication of this Case report
and any accompanying images. A copy of the written
consent is available for review by the Editor-in-Chief
of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
EMCS was the genetic counselor of the patient’s parents, co-evaluated the
patient’s aCGH analysis, designed the study (especially the cDNA analysis)
and drafted the manuscript. MS analyzed most of the aCGH data. EH and KB
were responsible for the medical treatment of the patient. KB helped with
the final version of the manuscript. LW carried out most of the molecular
genetic studies (aCGH, qPCR, sequence analysis). PB was responsible for the
aCGH analysis and helped with the final version of the manuscript. BZ
helped with the genetic counseling of the patient’s parents. SP helped
designing the study and drafting the final version of the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
We would like to thank the parents of the patient for their cooperation and
permission to publish photographs of the patient. Additionally, we are
grateful to Wolfgang Engel for his support and his critical reading of the
manuscript. We thank Sabine Herold for excellent technical assistance.
Author details
1Institute of Human Genetics, Georg August University, Heinrich-Düker-Weg
12, 37073 Göttingen, Germany. 2Department of Pediatrics and Pediatric
Neurology, Georg August University, Robert-Koch-Str. 40, 37075 Göttingen,
Germany.
Received: 27 August 2014 Accepted: 14 October 2014
References
1. Kleefstra T, Brunner HG, Amiel J, Oudakker AR, Nillesen WM, Magee A,
Geneviève D, Cormier-Daire V, van Esch H, Fryns JP, Hamel BC, Sistermans
EA, de Vries BB, van Bokhoven H: Loss-of-function mutations in euchromatin
histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric
deletion syndrome. Am J Hum Genet 2006, 79:370–377.
2. Stewart DR, Kleefstra T: The chromosome 9q subtelomere deletion
syndrome. Am J Med Genet C: Semin Med Genet 2007, 145C:383–392.
3. Kleefstra T, van Zelst-Stams WA, Nillesen WM, Cormier-Daire V, Houge G,
Foulds N, van Dooren M, Willemsen MH, Pfundt R, Turner A, Wilson M,
McGaughran J, Rauch A, Zenker M, Adam MP, Innes M, Davies C, López AG,
Casalone R, Weber A, Brueton LA, Navarro AD, Bralo MP, Venselaar H,
Stegmann SP, Yntema HG, van Bokhoven H, Brunner HG: Further clinical
and molecular delineation of the 9q subtelomeric deletion syndrome
supports a major contribution of EHMT1 haploinsufficiency to the core
phenotype. J Med Genet 2009, 46:598–606.
4. Willemsen MH, Vulto-van Silfhout AT, Nillesen WM, Wissink-Lindhout WM,
van Bokhoven H, Philip N, Berry-Kravis EM, Kini U, van Ravenswaaij-Arts CM,
Delle Chiaie B, Innes AM, Houge G, Kosonen T, Cremer K, Fannemel M,
Stray-Pedersen A, Reardon W, Ignatius J, Lachlan K, Mircher C, van den
Enden PT H, Mastebroek M, Cohn-Hokke PE, Yntema HG, Drunat S, Kleefstra
T: Update on Kleefstra syndrome. Mol Syndromol 2012, 2:202–212.
5. Yatsenko SA, Hixson P, Roney EK, Scott DA, Schaaf CP, Ng YT, Palmer R,
Fisher RB, Patel A, Cheung SW, Lupski JR: Human subtelomeric copy
number gains suggest a DNA replication mechanism for formation:
beyond breakage-fusion-bridge for telomere stabilization. Hum Genet
2012, 131:1895–1910.
6. Tomita-Mitchell A, Mahnke DK, Struble CA, Tuffnell ME, Stamm KD,
Hidestrand M, Harris SE, Goetsch MA, Simpson PM, Bick DP, Broeckel U,
Pelech AN, Tweddell JS, Mitchell ME: Human gene copy number spectra
analysis in congenital heart malformations. Physiol Genomics 2012,
44:518–541.7. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y: A complex
with chromatin modifiers that occupies E2F- and Myc-responsive genes
in G0 cells. Science 2002, 296:1132–1136.
8. Kleefstra T, Smidt M, Banning MJG, Oudakker AR, Van Esch H, de Brouwer
AP, Nillesen W, Sistermans EA, Hamel BC, de Bruijn D, Fryns JP, Yntema HG,
Brunner HG, de Vries BB, van Bokhoven H: Disruption of the gene
euchromatin histone methyl transferase1 (Eu-HMTase1) is associated
with the 9q34 subtelomeric deletion syndrome. J Med Genet 2005,
42:299–306.
9. Deininger PL, Batzer MA: Alu repeats and human disease. Mol Genet Metab
1999, 67:183–193.
10. RepeatMasker Web Server [http://www.repeatmasker.org]
11. Kleefstra T, Kramer JM, Neveling K, Willemsen MH, Koemans TS, Vissers LE,
Wissink-Lindhout W, Fenckova M, van den Akker WM, Kasri NN, Nillesen
WM, Prescott T, Clark RD, Devriendt K, van Reeuwijk J, de Brouwer AP,
Gilissen C, Zhou H, Brunner HG, Veltman JA, Schenck A, van Bokhoven H:
Disruption of an EHMT1-associated chromatin-modification module
causes intellectual disability. Am J Hum Genet 2012, 91:73–82.
doi:10.1186/s13039-014-0074-7
Cite this article as: Schwaibold et al.: Intragenic duplication of EHMT1
gene results in Kleefstra syndrome. Molecular Cytogenetics 2014 7:74.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
